feed,title,long_url,short_url
Benzinga,Outlook Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement,https://www.benzinga.com/pressreleases/20/12/g18592657/outlook-therapeutics-regains-compliance-with-nasdaq-minimum-bid-price-requirement,https://j.mp/3g6vXDH
